Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Phase 3 crawled date : 2021 - 03 - 15 save search
Histogen Announces Removal of Clinical Hold by FDA for HST-003 IND to Initiate a Phase 1/2 Trial for Knee Cartilage Regeneration
Published: 2021-03-15 (Crawled : 16:00) - biospace.com/
HSTO 4 d | $0.35 67.46% 5.4K
|
Health Technology
|
| O: 14.07%
H: 0.65%
C: -6.49%
fda phase 1 cartilage trial phase 3 phase 2 clinical hold
First Participants Dosed in Phase 1 Study Evaluating mRNA-1283, Moderna’s Next Generation COVID-19 Vaccine
Published: 2021-03-15 (Crawled : 15:00) - biospace.com/
MRNA | News S | $108.82 0.86% 0.85% 3.4M
|
Health Technology
|
| O: -0.16%
H: 5.18%
C: 5.04%
covid phase 1 vaccine phase 3 phase 2 covid-19
Subgroup Analysis from Phase 3 Clinical Trial Supports Efficacy of Maribavir Over Conventional Therapies in Transplant Recipients With Cytomegalovirus Infection (Refractory, With or Without Resistance)
Published: 2021-03-15 (Crawled : 15:00) - biospace.com/
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: 1.36%
H: 1.12%
C: 0.96%
phase 3 trial therapy injection infections
Rubius Therapeutics Reports Initial Clinical Data from Ongoing Phase 1/2 Trial of RTX-240 in Patients with Advanced Solid Tumors, Demonstrating Single-Agent Activity
Published: 2021-03-15 (Crawled : 13:00) - biospace.com/
RUBY | $0.057 -99.3% 760K
|
Health Technology
|
| O: 9.01%
H: 116.14%
C: 69.12%
solid tumors ongoing phase 1 trial phase 3 phase 2
Tonix Pharmaceuticals Achieves 50 Percent Enrollment in RALLY, the Second Phase 3 Study of TNX-102 SL for Management of Fibromyalgia
Published: 2021-03-15 (Crawled : 11:00) - globenewswire.com
TNXP | $0.1587 1.21% 1.2% 950K
|
Health Technology
|
| O: 2.91%
H: 4.74%
C: 0.24%
phase 3 fibromyalgia enroll
Ocuphire Announces MIRA-2 Phase 3 Registration Trial for the Reversal of Mydriasis Meets Primary Endpoint
Published: 2021-03-15 (Crawled : 11:00) - globenewswire.com
OCUP | News | $1.52 -1.3% -1.32% 90K
|
Health Technology
|
| O: 16.6%
H: 6.04%
C: -9.6%
phase 3 trial
Opthea Treats First Patient in Phase 3 Pivotal Trials of OPT-302 in Wet AMD
Published: 2021-03-15 (Crawled : 10:00) - globenewswire.com
OPT | News | $3.46 2.98% 2.89% 8.2K
|
Health Technology
|
| O: 6.06%
H: 3.7%
C: 0.72%
phase 3 trial dmd
Phase 3 trial of Libtayo® (cemiplimab) monotherapy in advanced cervical cancer stopped early for positive result on overall survival
Published: 2021-03-15 (Crawled : 07:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.85%
H: 0.89%
C: 0.6%
REGN | News | $906.55 -0.09% -0.08% 370K
|
Health Technology
|
| O: 0.33%
H: 2.47%
C: 2.31%
positive therapy cancer phase 3 trial
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.